Jack L. Treynor View PDF… Read more
Case Studies
CASE STUDIES: The Fed Watchers
Jack L. Treynor View PDF… Read more
CASE STUDIES: Poosha-Carta Food Stores
Jack L. Treynor View PDF… Read more
CASE STUDIES: Fiduciary Funds
Jack L. Treynor View PDF… Read more
CASE STUDIES: An Invitation to the Readers of JOIM
Jack L. Treynor View PDF… Read more
CASE STUDIES: Default-Shawnee Manufacturing
Jack L. Treynor View PDF… Read more
CASE STUDIES: A Prudent Man
Jack L. Treynor View PDF… Read more
CASE STUDIES: NEW FINANCING METHODS IN THE BIOPHARMA INDUSTRY: A CASE STUDY OF ROYALTY PHARMA, INC.
Andrew W. Lo and Sourya V. Naraharisetti The biotechnology and pharmaceutical industries are facing significant challenges to their existing business models because of expiring drug patents, declining risk tolerance of venture capitalists and other investors, and increasing complexity in translational medicine. In response to these challenges, new alternative investment companies have emerged to bridge the… Read more